Akso Health Group (AHG)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 7 | 2 | 6 | 13 | 2 | 15 | 14 | 10 |
| Operating profit | $m | -4 | -20 | ||||||
| Net profit | $m | -71 | -35 | -17 | -1 | -9 | -135 | -19 | -28 |
| EPS reported | $ | -0.03 | -0.07 | ||||||
| Operating cashflow per share | $ | -0.02 | -0.02 | ||||||
| Capex per share | $ | 0.24 | 0.00 | ||||||
| FCF per share | $ | -0.26 | -0.02 | ||||||
| Free cash flow | $m | -188 | -19 | ||||||
| Net debt | $m | 0 | 0 | ||||||
| Book value equity | $m | 181 | 181 | ||||||
| Book value per share | $ | 0.25 | 0.25 | ||||||
| Number of shares | m | 722.71 | 722.71 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 9.11 | 1.86 | ||||||
| P/S LTM | x | 119.13 | 32.56 | ||||||
| P/FCF LTM | x | -8.74 | -17.53 | ||||||
| EV/EBITDA LTM | x | -1,012.00 | -105.30 | ||||||
| EV/Sales LTM | x | 119.14 | 50.82 | ||||||
| Earnings Yield LTM | % | -1.13% | -15.53% | ||||||
| FCF Yield | % | -11.44% | -5.70% | ||||||
| Quality | |||||||||
| ROE | % | -10.32% | -50.15% | ||||||
| ROIC | % | -1.99% | -56.74% | ||||||
| Operating margin | % | -28.92% | -7.22% | ||||||
| Gross margin | % | -0.08% | -3.93% | ||||||
| FCF/Sales | % | -1362.5% | -113.58% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -6.40% | +327.97% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | - | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | -501.67 | -51.08 | ||||||
| Net Debt/EBITDA | x | -0.13 | -0.10 | ||||||
| EBIT/Net interest | x | 0.00 | 0.00 | ||||||
| Net debt/market cap | % | +0.02% | +0.05% | ||||||
| Net debt/Equity | x | 0.00 | 0.00 | ||||||
| Gross debt/equity | x | 0.00 | 0.00 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free